Genomic sequencing of DPC4 in the analysis of familial pancreatic carcinoma

Diagnostic Molecular Pathology

Volumn 6, Issue 2, 1997, Pages 85-90

  Moskaluk, Christopher A ^a   Hruban, Ralph H ^a   Schutte, Mieke ^a   Lietman, Amanda S ^a   Smyrk, Tom ^c   Fusaro, Lavonne ^c   Fusaro, Ramon ^c   Lynch, Jane ^c   Yeo, Charles J ^a   Jackson, Charles E ^b   Lynch, Henry T ^c   Kern, Scott E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer families; DPC4; Germline mutation; Pancreatic cancer

Indexed keywords

DNA;

ARTICLE; CLINICAL ARTICLE; FAMILIAL CANCER; GENE MUTATION; GENE SEQUENCE; GENOME; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PANCREAS CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CARCINOMA; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; MUTATION; NEOPLASTIC SYNDROMES, HEREDITARY; PANCREATIC NEOPLASMS; PEDIGREE; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; SMAD4 PROTEIN; TRANS-ACTIVATORS;

EID: 0030938595     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199704000-00003     Document Type: Article

References (21)

1. Baker SJ, Fearon ER, Nigro JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989;244:217-21.
2. Barrett MT, Schutte M, Kern SE, Reid BJ. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res 1996;56:4351-3.
3. Ghadirian P, Boyle P, Simard A, Baillargeon J, Maisonneuve P, Perret C. Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol 1991; 10:183-95.
4. INK4 mutations. N Engl J Med 1995;333:970-4.
5. Hahn SA, Hoque AT, Moskaluk CA, et al. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res 1996;56:490-4.
6. Hahn SA, Schutte M, Hoque AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-3.
7. Hussussian CJ, Struewing JP, Goldstein AM, et al. Germline p16 mutations in familial melanoma. Nature Genet 1994;8: 15-21.
8. Jen J, Harper JW, Bigner SH, et al. Deletion of p16 and p15 genes in brain tumors. Cancer Res 1994;54:6353-8.
9. Kamb A, Shattuck-Eidens D, Eeles R, et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet 1994;8:23-6.
10. Kim SK, Fan Y, Papadimitrakopoulou V, et al. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res 1996;56:2519-21.
11. Knudson AG. Antioncogenes and human cancer [Review]. Proc Natl Acad Sci USA 1993;90:10914-21.
12. Lynch HT, Fitzsimmons ML, Smyrk TC, Lanspa SJ, Watson P, McClellan J, Lynch JF. Familial pancreatic cancer: clinicopathologic study of 18 nuclear families. Am J Gastroenterol 1990;85:54-60.
13. Lynch HT, Fusaro L, Smyrk TC, Watson P, Lanspa S, Lynch JF. Medical genetic study of eight pancreatic cancer-prone families. Cancer Invest 1995;13:141-9.
14. Massague J. The transforming growth factor-β family [Review]. Ann Rev Cell Biol 1990;6:597-641.
15. Moskaluk CA, Kern SE. Cancer gets Mad: DPC4 and other TGFβ pathway genes in human cancer [Review]. Biochim Biophys Acta 1996;1288:M31-3.
16. Moskaluk CA, Hruban RH, Lietman AS, et al. Novel germline p16INK4a mutation in familial pancreatic carcinoma. Hum Mutat (1997, In press).
17. Nagatake M, Takagi Y, Osada N, et al. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res 1996;56:2718-20.
18. Schutte M, Hruban RH, Hedrick L, et al. DPC4 gene in various tumor types. Cancer Res 1996;56:2527-30.
19. Thiagalingam S, Lengauer C, Leach FS, et al. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nature Genet 1996;13:343-6.
20. Whelan AJ, Bartsch D, Goodfellow PJ. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N Engl J Med 1995;333:975-7.
21. Wooster R, Stratton MR. Breast cancer susceptibility: a complex disease unravels [Review]. Trends Genet 1995;11:3-5.